| Literature DB >> 36082030 |
Armin Ebrahimzadeh1, Mohsen Taghizadeh1, Alireza Milajerdi1.
Abstract
Background: COVID-19 is a highly transmissible viral infection with high morbidity. Few studies have been done about dietary intakes in patients with COVID-19. This study aimed to evaluate the association between major dietary patterns before COVID-19 diagnosis in recovered patients and the risk of disease severity and symptoms after the disease begins.Entities:
Keywords: COVID-19; dietary patterns; disease severity; inflammation; symptoms
Year: 2022 PMID: 36082030 PMCID: PMC9446542 DOI: 10.3389/fnut.2022.929384
Source DB: PubMed Journal: Front Nutr ISSN: 2296-861X
Figure 1Flowchart of the study's participants.
Factor loadings of food groups in major dietary patterns.
|
|
| ||
|---|---|---|---|
|
|
|
| |
| Egg | 0.427 | ||
| processed meat | 0.726 | ||
| Sweets and desserts | 0.543 | 0.466 | |
| Energy drinks | 0.833 | ||
| Visceral meats | |||
| Solid oils | 0.702 | 0.423 | |
| Junk foods | 0.679 | ||
| liquid oils | 0.550 | ||
| Salt | 0.459 | 0.526 | |
| Refined cereal | 0.657 | ||
| Whole grain | −0.684 | ||
| Flavor and pickle | 0.482 | 0.541 | |
| Chicken and fish | −0.606 | 0.555 | |
| Caffeine | 0.579 | ||
| Red meats | 0.432 | ||
| Vegetables | −0.675 | 0.461 | |
| Fruits and juice | −0.702 | 0.439 | |
| Low fat dairy products | −0.471 | −0.445 | |
| Nuts | 0.765 | ||
| High fat dairy products | 0.521 | ||
| Legume | −0.561 | 0.421 | |
General characteristics of participants across tertiles of dietary patterns.
|
|
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
| ||||||||
|
|
|
|
|
|
|
|
|
| ||
| Age (year) | 47.26 ± 11.33 | 43.80 ± 11.52 | <0.01 | 42.21 ± 12.28 | 43.04 ± 12.41 | 0.02 | 46.49 ± 11.66 | 41.62 ± 12.46 | 0.036 | |
| BMI (kg/m2) | 26.20 ± 3.01 | 29.27 ± 3.56 | <0.001 | 25.16 ± 2.77 | 27.96 ± 3.48 | <0.001 | 27.95 ± 3.4 | 26.24 ± 3.62 | <0.01 | |
| Physically active (%) | sedentary | 11(13.3) | 11(13.3) | 0.932 | 6(7.2) | 9(10.8) | 0.171 | 12(14.5) | 6(7.2) | 0.157 |
| moderate | 67(80.7) | 65(78.3) | 71(85.5) | 67(80.7) | 64(77.1) | 69(83.1) | ||||
| intense | 5(6) | 7(8.4) | 6(7.2) | 7(8.4) | 7(8.4) | 8(9.6) | ||||
| Gender (female) (%) | 42(50.6) | 44 (53.0) | 0.93 | 45(54.2) | 44(53.0) | 0.81 | 48(57.8) | 37(44.6) | 0.21 | |
| Overweight or obese (%) | 51 (61.4) | 75 (90.4) | <0.001 | 46 (55.4) | 64 (77.1) | 0.01 | 65 (78.3) | 47 (56.6) | 0.012 | |
| Supplements intake (%) | 79 (95.2) | 83 (100) | <0.01 | 75 (90.4) | 81 (97.6) | 0.08 | 78 (94) | 77 (92.8) | 0.34 | |
| Corticosteroids use (%) | 77 (92.8) | 83 (100) | <0.01 | 70 (84.3) | 81 (97.6) | <0.001 | 77 (92.8) | 74 (89.2) | 0.49 | |
| Antiviral drugs use (%) | 77 (92.8) | 83 (100) | <0.01 | 70 (84.3) | 81 (97.6) | <0.001 | 77 (92.8) | 74 (89.2) | 0.49 | |
Daily nutrient intake of all subjects across tertiles of dietary patterns.
|
|
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
| |||||||
|
|
|
|
|
|
|
|
|
| |
| Energy (Kcal/day) | 2653.89 ± 429.51 | 2926.94 ± 447.75 | <0.001 | 2586.39 ± 503.03 | 2894.68 ± 416.27 | <0.001 | 2551.5 ± 529.97 | 2892.26 ± 414.30 | <0.001 |
| Protein (g/day) | 111.59 ± 18.54 | 105.20 ± 11.12 | 0.052 | 106 ± 21.85 | 111.21 ± 15.36 | 0.122 | 92.84 ± 15.86 | 121.23 ± 11.15 | <0.001 |
| Carbohydrate (g/day) | 408.33 ± 54.36 | 431.69 ± 43.66 | <0.001 | 385.43 ± 59.31 | 437.58 ± 45.31 | <0.001 | 391.52 ± 62.2 | 422.07 ± 49.72 | <0.001 |
| Fat (g/day) | 87.65 ± 20.69 | 120.83 ± 21.49 | <0.001 | 90.6 ± 28.53 | 106.80 ± 23.60 | <0.001 | 84.73 ± 30.8 | 108.41 ± 16.91 | <0.001 |
| Dietary fiber (g/day) | 26.57 ± 3.9 | 19.44 ± 1.8 | <0.001 | 23.46 ± 4.44 | 23.33 ± 5.33 | 0.58 | 20.05 ± 4.4 | 26.38 ± 4.7 | <0.001 |
| Vitamin D | 2.01 ± 0.58 | 2.59 ± 0.72 | <0.001 | 2.14 ± 0.79 | 2.45 ± 0.64 | 0.019 | 2.1 ± 0.97 | 2.32 ± 0.57 | 0.032 |
| Vitamin A | 1438 ± 322 | 1175 ± 166 | <0.001 | 1346 ± 424 | 1341 ± 274 | 0.299 | 1139 ± 281 | 1461 ± 271 | <0.001 |
| Vitamin E | 6.8 ± 1.6 | 8.5 ± 2.24 | <0.001 | 5.8 ± 1.46 | 8.1 ± 1.99 | <0.001 | 6.64 ± 2.33 | 7.06 ± 1.4 | <0.01 |
| Vitamin C | 165.5 ± 31.64 | 111.5 ± 13.5 | <0.001 | 144.32 ± 30.94 | 138.14 ± 42.86 | 0.282 | 113.55 ± 31.36 | 162.04 ± 29.34 | <0.001 |
| Vitamin B1 | 2.56 ± 0.37 | 2.5 ± 0.3 | <0.01 | 2.3 ± 0.37 | 2.65 ± 0.3 | <0.001 | 2.35 ± 0.37 | 2.6 ± 0.32 | <0.001 |
| Vitamin B6 | 1.78 ± 0.3 | 1.59 ± 0.27 | <0.001 | 1.69 ± 0.33 | 1.66 ± 0.32 | 0.222 | 1.39 ± 0.25 | 1.9 ± 0.15 | <0.001 |
| Vitamin B9 | 466.44 ± 85.29 | 357.78 ± 40.25 | <0.001 | 426.53 ± 95.3 | 411.69 ± 96.76 | 0.47 | 347.86 ± 85.53 | 484.76 | <0.001 |
| Vitamin B12 | 4.74 ± 1.24 | 3.72 ± 0.62 | <0.001 | 3.99 ± 1.5 | 4.28 ± 1.02 | 0.273 | 3.39 ± 1.14 | 4.8 ± 0.91 | <0.001 |
| Zinc | 10.45 ± 1.74 | 10.01 ± 1.16 | 0.24 | 10.35 ± 2.37 | 10.28 ± 1.53 | 0.923 | 8.6 ± 1.6 | 11.6 ± 1.1 | <0.001 |
| Calcium | 951.11 ± 145.57 | 867.2 ± 76.08 | <0.001 | 906.7 ± 164.05 | 945.5 ± 134.4 | <0.01 | 823.93 ± 136.49 | 998.9 ± 111.8 | <0.001 |
| Magnesium | 354.68 ± 55.12 | 306.79 ± 25.68 | <0.001 | 321.76 ± 60.5 | 336.83 ± 54.62 | 0.187 | 282.4 ± 49.23 | 370.16 ± 37 | <0.001 |
Inflammatory biomarkers across tertiles of dietary patterns.
|
| ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
| ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
| |
| CRP (mg/dl) | 10.61 ± 14.85 | 35.62 ± 24.29 | <0.001 | <0.001 | 12.63 ± 18.43 | 25.3 ± 24.44 | <0.01 | <0.001 | 26.14 ± 25.5 | 11.89 ± 12.42 | <0.001 | <0.001 |
| ESR (mm/hr) | 15 ± 16 | 41.65 ± 29.83 | <0.001 | <0.001 | 16.96 ± 16.57 | 31.33 ± 30.66 | <0.01 | <0.001 | 33.9 ± 29.88 | 15.62 ± 11.69 | <0.001 | <0.001 |
Adjusted for sex, age, BMI, physical activity and energy intake.
Odds ratio (95% CI) of severe disease in relation to major dietary patterns.
|
| |||||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
| |||||||
|
|
|
|
|
|
|
|
|
| |
| Crude | 1 | 4.34 (2.26, 8.34) | <0.001 | 1 | 3.37 (1.77, 6.42) | <0.001 | 1 | 0.25 (0.13, 0.49) | <0.001 |
| Model 1 | 1 | 5.06 (2.51, 10.21) | <0.001 | 1 | 3.61 (1.81, 7.19) | <0.001 | 1 | 0.22 (0.1, 0.45) | <0.001 |
| Model 2 | 1 | 4.57 (2.34, 9.64) | <0.01 | 1 | 3.13 (1.55, 6.3) | <0.01 | 1 | 0.21 (0.1, 0.45) | <0.01 |
| Model 3 | 1 | 3.23 (1.53, 6.81) | <0.01 | 1 | 2.17 (1.03, 4.54) | 0.04 | 1 | 0.31 (0.14, 0.68) | <0.01 |
Model 1, Adjusted for sex, age and energy intake; Model 2, Further adjusted for physical activity, supplement use, corticosteroids use, and antiviral drugs use; Model 3, Further adjusted for BMI.
Odds ratio (95% CI) for symptoms of COVID−19 according to major dietary patterns.
|
| |||||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
| |||||||
|
|
|
|
|
|
|
|
|
| |
|
| |||||||||
| Crude | 1 | 3.37 (1.83, 7.75) | <0.001 | 1 | 3.2 (1.69, 6.19) | <0.001 | 1 | 0.28 (0.14, 0.55) | <0.001 |
| Model 1 | 1 | 3.8 (1.81, 8.2) | <0.01 | 1 | 3.25 (1.62, 6.52) | <0.01 | 1 | 0.21 (0.1, 0.46) | <0.001 |
| Model 2 | 1 | 3.46 (1.61, 7.4) | <0.01 | 1 | 2.79 (1.36, 5.7) | <0.01 | 1 | 0.2 (0.08, 0.45) | <0.001 |
| Model 3 | 1 | 2.4 (1.08, 5.36) | 0.53 | 1 | 2.07 (0.98, 4.37) | 0.51 | 1 | 0.27 (0.11, 0.63) | <0.01 |
|
| |||||||||
| Crude | 1 | 8.31 (3.56, 19.38) | <0.001 | 1 | 4.04 (2.09, 7.82) | <0.001 | 1 | 0.44 (0.23, 0.83) | 0.01 |
| Model 1 | 1 | 8.74 (3.62, 21.08) | <0.001 | 1 | 4.05 (2.02, 8.1) | <0.001 | 1 | 0.35 (0.17, 0.7) | <0.01 |
| Model 2 | 1 | 8.7 (3.61, 21.32) | <0.001 | 1 | 3.83 (1.89, 7.79) | <0.001 | 1 | 0.36 (0.17, 0.73) | <0.01 |
| Model 3 | 1 | 6.21 (2.5, 15.45) | <0.01 | 1 | 2.79 (1.32, 5.92) | <0.01 | 1 | 0.55 (0.259, 1.19) | 0.15 |
|
| |||||||||
| Crude | 1 | 10.6 (3.52, 31.9) | <0.001 | 1 | 3.21 (1.53, 6.73) | <0.01 | 1 | 1 (0.49, 2.36) | 0.85 |
| Model 1 | 1 | 11.44 (3.71, 35.29) | <0.001 | 1 | 3.24 (1.49, 7.08) | <0.01 | 1 | 1.1 (0.47, 2.57) | 0.79 |
| Model 2 | 1 | 10.92 (3.52, 33.8) | <0.001 | 1 | 2.9 (1.3, 6.47) | <0.01 | 1 | 0.65 (1.22, 0.51 | 0.65 |
| Model 3 | 1 | 9.07 (2.83, 28.98) | <0.001 | 1 | 2.36 (1.03, 5.39) | 0.03 | 1 | 1.71 (0.69, 4.27) | 0.17 |
|
| |||||||||
| Crude | 1 | 14.32 (4.15, 49.37) | <0.001 | 1 | 3.52 (1.65, 7.5) | <0.01 | 1 | 1 (0.45, 2.2) | 1 |
| Model 1 | 1 | 16.43 (4.63, 58.21) | <0.001 | 1 | 3.65 (1.65, 8.07) | <0.01 | 1 | 1.06 (0.45, 2.47) | 0.85 |
| Model 2 | 1 | 15.68 (4.41, 55.73) | <0.001 | 1 | 3.26 (1.44, 7.36) | <0.01 | 1 | 1.16 (0.48, 2.78) | 0.71 |
| Model 3 | 1 | 12.21 (3.34, 44.64) | <0.001 | 1 | 2.55 (1.1, 5.92) | 0.02 | 1 | 1.75 (0.69, 4.43) | 0.15 |
|
| |||||||||
| Crude | 1 | 2.69 (1.35, 5.36) | <0.01 | 1 | 0.88 (0.44, 1.75) | 0.73 | 1 | 0.21 (0.1, 0.44) | <0.001 |
| Model 1 | 1 | 2.96 (1.42, 6.19) | <0.01 | 1 | 0.75 (0.36, 1.57) | 0.45 | 1 | 0.19 (0.08, 0.41) | <0.001 |
| Model 2 | 1 | 3.08 (1.44, 6.56) | <0.01 | 1 | 0.73 (0.34, 1.56) | 0.41 | 1 | 0.18 (0.08, 0,41) | <0.001 |
| Model 3 | 1 | 2.25 (1.01, 5) | 0.04 | 1 | 0.5(0.22, 1.12) | 0.087 | 1 | 0.22 (0.1, 0.51) | <0.001 |
|
| |||||||||
| Crude | 1 | 0.25 (0.13, 0.48) | <0.001 | 1 | 1.05 (0.56, 1.96) | 0.87 | 1 | 0.47 (0.25, 0.88) | 0.019 |
| Model 1 | 1 | 3.63 (1.83, 7.2) | <0.001 | 1 | 0.95 (0.48, 1.85) | 0.87 | 1 | 0.47 (0.24, 0.95) | 0.03 |
| Model 2 | 1 | 3.5 (1.76, 6.99) | <0.001 | 1 | 0.85 (0.43, 1.68) | 0.632 | 1 | 0.49 (0.24, 0.97) | 0.04 |
| Model 3 | 1 | 2.91 (1.41, 6) | <0.01 | 1 | 0.61 (0.29, 1.26) | 0.182 | 1 | 0.64 (0.31, 1.3) | 0.23 |
|
| |||||||||
| Crude | 1 | 0.15 (0.05, 0.43) | <0.001 | 1 | 2.6 (0.94, 7.1) | 0.07 | 1 | 0.24 (0.08, 0.711) | <0.01 |
| Model 1 | 1 | 7.25 (2.31, 22.69) | <0.001 | 1 | 1.06 (0.458, 2.49) | 0.17 | 1 | 0.16 (0.05, 0.49) | <0.01 |
| Model 2 | 1 | 6.84 (2.18, 21.47) | <0.001 | 1 | 1.88 (0.66, 5.37) | 0.29 | 1 | 0.16 (0.05, 0.16) | <0.01 |
| Model 3 | 1 | 5.71 (1.74, 18.71) | <0.01 | 1 | 1.29 (0.43, 3.89) | 0.75 | 1 | 0.22 (0.07, 0.71) | 0.48 |
|
| |||||||||
| Crude | 1 | 9.2 (4.1, 20.96) | <0.001 | 1 | 1 (0.5, 1.99) | 1 | 1 | 0.3 (0.14, 0.63) | <0.01 |
| Model 1 | 1 | 11.08 (4.71, 26) | <0.001 | 1 | 0.9 (0.44, 1.86) | 0.76 | 1 | 0.27 (0.12, 0.58) | <0.01 |
| Model 2 | 1 | 12.3 (5.1, 29.8) | <0.001 | 1 | 0.92 (0.44, 1.9) | 0.78 | 1 | 0.26 (0.12, 0.58) | <0.01 |
| Model 3 | 1 | 9.6 (3.88, 23.77) | <0.001 | 1 | 0.62 (0.28, 1.37) | 0.2 | 1 | 0.36 (0.16, 0.8) | 0.01 |
Model 1, Adjusted for sex, age and energy intake; Model 2, Further adjusted for physical activity, supplement use, corticosteroids use, and antiviral drugs use; Model 3, Further adjusted for BMI.
Odds ratio (95% CI) for hospital stay and convalescence duration according to major dietary patterns.
|
| |||||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
| |||||||
|
|
|
|
|
|
|
|
|
| |
|
| |||||||||
| Crude | 1 | 2.74 (1.42, 5,29) | <0.01 | 1 | 3.59 (1.74, 7.39) | <0.01 | 1 | 0.39 (0.19, 0.77) | <0.01 |
| Model 1 | 1 | 3.65 (1.69, 7.92) | <0.01 | 1 | 4.04 (1.75, 9.34) | <0.01 | 1 | 0.37 (0.16, 0.84) | 0.017 |
| Model 2 | 1 | 3.23 (1.49, 7) | <0.01 | 1 | 3.64 (1.55, 8.57) | <0.01 | 1 | 0.36 (0.15, 0.83) | 0.016 |
| Model 3 | 1 | 2.87 (1.28, 6.45) | 0.015 | 1 | 2.97 (1.23, 7.15) | 0.011 | 1 | 0.44 (0.18, 1.06) | 0.068 |
|
| |||||||||
| Crude | 1 | 2.7 (1.38, 5.29) | <0.01 | 1 | 1.22 (0.65, 2.26) | 0.52 | 1 | 0.24 (0.12, 0.47) | <0.01 |
| Model 1 | 1 | 3.48 (1.7, 7.1) | <0.01 | 1 | 1.3 (0.67, 2.5) | 0.44 | 1 | 0.26 (0.13, 0.53) | <0.01 |
| Model 2 | 1 | 3.64 (1.77, 7.48) | <0.01 | 1 | 1.35 (0.69, 2.65) | 0.39 | 1 | 0.25 (0.12, 0.52) | <0.01 |
| Model 3 | 1 | 1.06 (0.97, 1.16) | <0.01 | 1 | 1.04 (0.51, 2.11) | 0.91 | 1 | 0.32 (0.15, 0.68) | <0.01 |
Model 1, Adjusted for sex, age and energy intake; Model 2, Further adjusted for physical activity, supplement use, corticosteroids use, and antiviral drugs use. Model 3, Further adjusted for BMI.